Kraig Biocraft Announces Breakthrough in Developing Immortalized Silk Gland Cell Line
Kraig Biocraft Laboratories (OTCMKTS: KBLB) announced the successful development of an immortalized silk gland cell line, which could support future applications in biopharmaceutical manufacturing and advanced biomaterials. The company highlighted early testing results showing stable viability, strong proliferation capacity, and high recombinant protein expression.
Topics: biopharmaceutical manufacturing recombinant proteins silk gland cells